BIOMAT Database Logo BIOMAT Database Logo

SARS-CoV-2: Virology, epidemiology, immunology and vaccine development. 2020

Marc Baay, and Bruno Lina, and Arnaud Fontanet, and Arnaud Marchant, and Melanie Saville, and Philippe Sabot, and Philippe Duclos, and Joris Vandeputte, and Pieter Neels
P95 Epidemiology & Pharmacovigilance, Leuven, Belgium. Electronic address: marc.baay@p-95.com.

This first International Alliance for Biological Standardization Covid-19 webinar brought together a broad range of international stakeholders, including academia, regulators, funders and industry, with a considerable delegation from low- and middle-income countries, to discuss the virology, epidemiology and immunology of, and the vaccine development for SARS-CoV-2.

UI MeSH Term Description Entries
D007391 International Cooperation The interaction of persons or groups of persons representing various nations in the pursuit of a common goal or interest. Foreign Aid,Treaties,Aid, Foreign,Cooperation, International,Treaty
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011024 Pneumonia, Viral Inflammation of the lung parenchyma that is caused by a viral infection. Pneumonias, Viral,Viral Pneumonia,Viral Pneumonias
D012015 Reference Standards A basis of value established for the measure of quantity, weight, extent or quality, e.g. weight standards, standard solutions, methods, techniques, and procedures used in diagnosis and therapy. Standard Preparations,Standards, Reference,Preparations, Standard,Standardization,Standards,Preparation, Standard,Reference Standard,Standard Preparation,Standard, Reference
D003226 Congresses as Topic Works about conferences, conventions or formal meetings usually attended by delegates representing a special field of interest. Conferences,Conference Proceedings as Topic,Conferences and Congresses,Conferences and Proceedings,Congresses and Conferences,Professional Meetings and Conferences,Congresses as Topics,Proceedings and Conferences,Topics, Congresses as
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000073640 Betacoronavirus A genus of the family CORONAVIRIDAE which causes respiratory or gastrointestinal disease in a variety of mostly mammals. Human betacoronaviruses include HUMAN ENTERIC CORONAVIRUS; HUMAN CORONAVIRUS OC43; MERS VIRUS; and SEVERE ACUTE RESPIRATORY SYNDROME-RELATED CORONAVIRUS. Members have either core transcription regulatory sequences of 5’-CUAAAC-3’ or 5’-CUAAAC-3’ and mostly have no ORF downstream to the N protein gene. HCoV-HKU1,Human coronavirus HKU1,Pipistrellus bat coronavirus HKU5,Rousettus bat coronavirus HKU9,Tylonycteris bat coronavirus HKU4,Betacoronaviruses
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19

Related Publications

Marc Baay, and Bruno Lina, and Arnaud Fontanet, and Arnaud Marchant, and Melanie Saville, and Philippe Sabot, and Philippe Duclos, and Joris Vandeputte, and Pieter Neels
SARS-CoV-2 Virology.
June 2022, Infectious disease clinics of North America,
Marc Baay, and Bruno Lina, and Arnaud Fontanet, and Arnaud Marchant, and Melanie Saville, and Philippe Sabot, and Philippe Duclos, and Joris Vandeputte, and Pieter Neels
[The virology of SARS-CoV-2].
August 2020, Der Internist,
Marc Baay, and Bruno Lina, and Arnaud Fontanet, and Arnaud Marchant, and Melanie Saville, and Philippe Sabot, and Philippe Duclos, and Joris Vandeputte, and Pieter Neels
[The virology of SARS-CoV-2].
January 2020, Der Pneumologe,
Marc Baay, and Bruno Lina, and Arnaud Fontanet, and Arnaud Marchant, and Melanie Saville, and Philippe Sabot, and Philippe Duclos, and Joris Vandeputte, and Pieter Neels
[The virology of SARS-CoV-2].
January 2020, Der Gastroenterologe : Zeitschrift fur Gastroenterologie und Hepatologie,
Marc Baay, and Bruno Lina, and Arnaud Fontanet, and Arnaud Marchant, and Melanie Saville, and Philippe Sabot, and Philippe Duclos, and Joris Vandeputte, and Pieter Neels
Basic virology of SARS-CoV 2.
January 2022, Indian journal of medical microbiology,
Marc Baay, and Bruno Lina, and Arnaud Fontanet, and Arnaud Marchant, and Melanie Saville, and Philippe Sabot, and Philippe Duclos, and Joris Vandeputte, and Pieter Neels
Immunology to Immunotherapeutics of SARS-CoV-2: Identification of Immunogenic Epitopes for Vaccine Development.
September 2022, Current microbiology,
Marc Baay, and Bruno Lina, and Arnaud Fontanet, and Arnaud Marchant, and Melanie Saville, and Philippe Sabot, and Philippe Duclos, and Joris Vandeputte, and Pieter Neels
Rubella: Epidemiology, virology, and immunology.
March 1967, The American journal of the medical sciences,
Marc Baay, and Bruno Lina, and Arnaud Fontanet, and Arnaud Marchant, and Melanie Saville, and Philippe Sabot, and Philippe Duclos, and Joris Vandeputte, and Pieter Neels
SARS-CoV-2 Vaccine Development: Current Status.
October 2020, Mayo Clinic proceedings,
Marc Baay, and Bruno Lina, and Arnaud Fontanet, and Arnaud Marchant, and Melanie Saville, and Philippe Sabot, and Philippe Duclos, and Joris Vandeputte, and Pieter Neels
SARS-CoV-2: Targeted managements and vaccine development.
April 2021, Cytokine & growth factor reviews,
Marc Baay, and Bruno Lina, and Arnaud Fontanet, and Arnaud Marchant, and Melanie Saville, and Philippe Sabot, and Philippe Duclos, and Joris Vandeputte, and Pieter Neels
SARS-CoV-2 vaccine development, access, and equity.
November 2020, The Journal of experimental medicine,
Copied contents to your clipboard!